As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Pfizer CEO Albert Bourla revealed to stakeholders this week that the rendezvous took place in December, a few weeks after RFK Jr was nominated to head the Department of Health and Human Services ...

Pfizer CEO Albert Bourla has revealed that he recently dined with health secretary nominee and vaccine skeptic Robert F.

Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more ...

Analysts believe it bodes poorly for vaccine makers. But Pfizer (PFE) CEO Albert Bourla said he doesn't think so, in an interview with Yahoo Finance. In fact, he said that RFK's views on vaccines ...